Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comprehensive digital debulking and reconstruction for pediatric foot macrodactyly.

Created on 30 Oct 2026

Authors

Aiping Yu, Lei Huang, Razzokov Anvar Sardor O G'li, Wei Ding, Wenhai Sun

Published in

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons. Oct 16, 2026. Epub Oct 16, 2026.

Abstract

Traditional treatments for pediatric foot macrodactyly often yield suboptimal outcomes and require multiple surgeries. This study evaluates a novel single-stage technique: Comprehensive Digital Debulking and Reconstruction (CDDR).
CDDR uses pedicled thin flaps for radical soft-tissue excision, combined with osteotomy and joint fusion. We retrospectively reviewed 36 children (mean age, 5.4 years) treated with this procedure. Outcomes included morphometric ratios, AOFAS and Maryland scores, Vancouver Scar Scale, parental satisfaction, and complications.
At mean 3.0-year follow-up, all toe, forefoot, and nail size ratios significantly improved (all p < 0.01). AOFAS scores increased from 57.9 to 77.3 and Maryland scores from 75.5 to 91.4. Mean Vancouver Scar Scale was 1.6; all parents were satisfied. Complications included skin necrosis (5.6%), hypertrophic scar (5.6%), toe deviation (2.8%), and delayed union (2.8%).
CDDR is a safe, effective, single-stage toe-preserving alternative to amputation for pediatric foot macrodactyly.
III.

PMID:
42957486
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement